SCHEMBL28028864

SCHEMBL28028864

Nc1cc(Cl)ccc1NCC1CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 4/20 0.54
TSHR P16473 3/20 0.41
CYP3A4 P08684 3/20 0.41
ALDH1A1 P00352 2/20 0.41
ALOX15 P16050 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
CNR2 P34972 2/20 0.40
TP53 P04637 1/20 0.39
LIPC P11150 1/20 0.38
LIPG Q9Y5X9 1/20 0.38
CNR1 P21554 1/20 0.38
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
HPGD P15428 1/20 0.37
ALOX12 P18054 1/20 0.37
MAPK1 P28482 1/20 0.37
HSD17B10 Q99714 1/20 0.37
STK4 Q13043 1/20 0.37
STK3 Q13188 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2578339 0.89 PTGER4 (0.44) PTGER4CYP3A4CNR2CNR1HDAC1
SCHEMBL16254681 0.85 PTGER4 (0.40) PTGER4TSHRCYP3A4ALDH1A1ALOX15
SCHEMBL15099940 0.80 PTGER4 (0.44) PTGER4TSHRCYP3A4ALDH1A1ALOX15
SCHEMBL9604228 0.79 PTGER4 (0.58) PTGER4CYP3A4ALDH1A1ALOX15SMN1; SMN2
SCHEMBL3133410 0.79 PTGER4 (0.54) PTGER4LIPCLIPGMAPT
SCHEMBL8885032 0.79 PTGER4 (0.43) PTGER4TSHRCYP3A4ALDH1A1ALOX15
SCHEMBL11935246 0.79 PTGER4 (0.47) PTGER4CYP3A4ALDH1A1SMN1; SMN2CNR2
SCHEMBL13438926 0.79 PTGER4 (0.47) PTGER4CYP3A4ALDH1A1SMN1; SMN2CNR2
SCHEMBL27270334 0.77 PTGER4 (0.55) PTGER4TSHRCYP3A4ALDH1A1ALOX15
SCHEMBL7820003 0.76 PTGER4 (0.54) PTGER4CYP3A4ALDH1A1SMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104854098-B Benzimidazole derivatives as EP4 antagonists 拜耳医药股份公司 2018-01-09 CN disclosed
CN-104854098-A NOVEL BENZIMIDAZOLE DERIVATIVES AS EP4 ANTAGONISTS Bayer Pharma AG 2015-08-19 CN disclosed